Skip to content

Praxis Precision Medicines, Inc. PRAX Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue--100%
Operating income-$105.9M-41.7%
Net income-$92.6M-33.6%
EPS (diluted)-$3.20+2.7%

Balance sheet

See full
Cash & equivalents$536.7M+223%
Total debt$1.4M+31.3%
Total equity$1.4B+221%
Total assets$1.5B+205%

Cash flow

See full
Operating cash flow-$86.2M-62.5%
CapEx$62.0K
Free cash flow-$86.2M-62.6%

Valuation

See full
Market cap$7.87B+1,075%
Enterprise value$7.34B+1,309%

Profitability

See full
Operating margin-3,927.5%-1,497pp
Net margin-3,658.5%-1,388pp
FCF margin-3,067.4%-1,030pp

Returns & leverage

See full
Return on equity-35.3%-10.9pp
Debt / equity0.0×
Current ratio15.9×+7.4×

Where this comes from

Reported directly by Praxis Precision Medicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Praxis Precision Medicines, Inc.'s common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Praxis Precision Medicines, Inc.'s common stock, shares issued (in shares)?
Praxis Precision Medicines, Inc. (PRAX) reported common stock, shares issued (in shares) of $27.86M in Q1 2026.
How has Praxis Precision Medicines, Inc.'s common stock, shares issued (in shares) changed year-over-year?
Praxis Precision Medicines, Inc.'s common stock, shares issued (in shares) increased by 37.0% year-over-year, from $20.34M to $27.86M.
What is the long-term trend for Praxis Precision Medicines, Inc.'s common stock, shares issued (in shares)?
Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s common stock, shares issued (in shares) has grown at a -8.0% compound annual growth rate (CAGR), from $38.27M to $25.2M.